首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1729254

日本新一代定序市場報告（依定序類型、產品類型、技術、應用、最終使用者和地區）2025-2033

Japan Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End User, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年日本次世代定序市場規模達11億美元。展望未來， IMARC Group預計到2033年市場規模將達到79億美元，2025-2033年期間的成長率（CAGR）為22.4%。癌症和遺傳疾病等慢性疾病的發生率不斷上升，增加了對先進基因檢測和定序技術的需求，從而推動了市場的發展。

次世代定序 (NGS) 是一種高通量、大規模平行 DNA 定序技術，可快速且經濟高效地分析整個基因組、轉錄組和表觀基因組。 NGS 可同時對數百萬個 DNA 片段進行定序，從而可以在一次運行中產生大量資料。該技術促進了基因變異、基因表現模式的研究以及致病突變的識別，徹底改變了基因組學研究和生物醫學應用。 NGS 具有多種應用，包括全基因組定序、外顯子定序、RNA 定序和 ChIP 定序等。它大大加快了生物和醫學研究的步伐，促進了個人化醫療、疾病診斷和複雜生物過程的理解的進步。然而，資料分析、儲存和解釋等挑戰仍然存在，需要開發強大的生物資訊學工具和計算技術，以充分利用NGS在各個科學領域的潛力。

日本下一代定序市場趨勢：

日本的下一代定序市場正在經歷快速成長，主要受到幾個關鍵因素的推動。首先，區域性慢性病盛行率的不斷上升增加了對先進診斷工具的需求，推動了NGS技術的採用。因此，醫療保健提供者擴大將 NGS 整合到他們的臨床實踐中，旨在提供個人化治療並改善患者的治療效果。此外，基因組定序成本的大幅下降大大拓寬了NGS平台的可近性，從而促進了其在研究和臨床環境中的廣泛應用。此外，對精準醫療的日益關注以及基因組學在藥物發現和開發中日益成長的重要性增強了對 NGS 的需求，促進了生物技術公司和研究機構之間的合作，以加快將基因組學見解轉化為靶向療法。此外，生物資訊學工具和資料分析技術的不斷進步，促進了複雜基因組資料的解釋，從而刺激了各個領域採用 NGS 技術，預計將在預測期內推動日本 NGS 市場的發展。

日本次世代定序市場細分：

定序類型洞察：

全基因組定序
標靶重測序
全外顯子定序
RNA定序
CHIP定序
從頭測序
甲基化定序
其他

產品類型洞察：

儀器
試劑和耗材
軟體和服務

技術洞察：

邊合成邊定序
離子半導體定序
單分子即時定序
奈米孔定序
其他

應用程式洞察：

生物標記與癌症
藥物研發與個人化醫療
基因篩檢
診斷
農業和動物研究
其他

最終用戶洞察：

學術機構與研究中心
醫院和診所
製藥和生物技術公司
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本下一代定序市場目前表現如何，未來幾年將如何表現？
COVID-19 對日本下一代定序市場有何影響？
根據定序類型，日本次世代定序市場是如何分類的？
根據產品類型，日本次世代定序市場是如何分類的？
日本次世代定序市場依技術分類的分佈是怎麼樣的？
日本下一代定序市場根據應用如何分類？
根據最終用戶，日本下一代定序市場是如何分類的？
日本次世代定序市場的價值鏈分為哪些階段？
日本下一代定序的關鍵促進因素和挑戰是什麼？
日本次世代定序市場的結構是怎麼樣的？主要參與者是誰？
日本新世代定序市場的競爭程度如何？

本報告回答的關鍵問題：

日本下一代定序市場目前表現如何，未來幾年將如何表現？
COVID-19 對日本下一代定序市場有何影響？
根據定序類型，日本次世代定序市場是如何分類的？
根據產品類型，日本次世代定序市場是如何分類的？
日本次世代定序市場依技術分類的分佈是怎麼樣的？
日本下一代定序市場根據應用如何分類？
根據最終用戶，日本下一代定序市場是如何分類的？
日本次世代定序市場的價值鏈分為哪些階段？
日本下一代定序的關鍵促進因素和挑戰是什麼？
日本次世代定序市場的結構是怎麼樣的？主要參與者是誰？
日本新世代定序市場的競爭程度如何？

Japan next-generation sequencing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.9 Billion by 2033, exhibiting a growth rate (CAGR) of 22.4% during 2025-2033. The escalating incidence of chronic diseases, such as cancer and genetic disorders, which has increased the demand for advanced genetic testing and sequencing technologies, is driving the market.

Next-generation sequencing (NGS) is a high-throughput, massively parallel DNA sequencing technology that enables the rapid and cost-effective analysis of entire genomes, transcriptomes, and epigenomes. NGS simultaneously sequences millions of DNA fragments, allowing for the generation of large volumes of data in a single run. This technology has revolutionized genomics research and biomedical applications by facilitating the study of genetic variations, gene expression patterns, and the identification of disease-causing mutations. NGS has diverse applications, including whole-genome sequencing, exome sequencing, RNA sequencing, and ChIP sequencing, among others. It has significantly accelerated the pace of biological and medical research, contributing to advances in personalized medicine, disease diagnosis, and the understanding of complex biological processes. However, challenges such as data analysis, storage, and interpretation remain, requiring the development of robust bioinformatics tools and computational techniques to fully harness the potential of NGS in various scientific fields.

Japan Next-Generation Sequencing Market Trends:

The next-generation sequencing market in Japan is experiencing rapid growth, largely fueled by several key factors. Firstly, the increasing prevalence of chronic diseases regionally has heightened the demand for advanced diagnostic tools, propelling the adoption of NGS technologies. Consequently, healthcare providers are increasingly integrating NGS into their clinical practices, aiming to offer personalized treatments and enhance patient outcomes. Moreover, the plummeting costs associated with genome sequencing have significantly broadened the accessibility of NGS platforms, thereby encouraging their widespread utilization across research and clinical settings. Additionally, the escalating focus on precision medicine and the rising significance of genomics in drug discovery and development has bolstered the demand for NGS, fostering collaborations between biotechnology firms and research institutions to expedite the translation of genomic insights into targeted therapies. Furthermore, the continual advancements in bioinformatics tools and data analysis techniques, which have facilitated the interpretation of complex genomic data, thereby stimulating the adoption of NGS technologies in various fields, are expected to drive the NGS market in Japan during the forecast period.

Japan Next-Generation Sequencing Market Segmentation:

Sequencing Type Insights:

Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
Others

Product Type Insights:

Instruments
Reagents and Consumables
Software and Services

Technology Insights:

Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others

Application Insights:

Biomarker and Cancer
Drug Discovery and Personalized Medicine
Genetic Screening
Diagnostics
Agriculture and Animal Research
Others

End User Insights:

Academic Institutes and Research Centers
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan next-generation sequencing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan next-generation sequencing market?
What is the breakup of the Japan next-generation sequencing market on the basis of sequencing type?
What is the breakup of the Japan next-generation sequencing market on the basis of product type?
What is the breakup of the Japan next-generation sequencing market on the basis of technology?
What is the breakup of the Japan next-generation sequencing market on the basis of application?
What is the breakup of the Japan next-generation sequencing market on the basis of end user?
What are the various stages in the value chain of the Japan next-generation sequencing market?
What are the key driving factors and challenges in the Japan next-generation sequencing?
What is the structure of the Japan next-generation sequencing market and who are the key players?
What is the degree of competition in the Japan next-generation sequencing market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Next-Generation Sequencing Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Next-Generation Sequencing Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Next-Generation Sequencing Market - Breakup by Sequencing Type

6.1 Whole Genome Sequencing
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Targeted Resequencing
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Whole Exome Sequencing
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 RNA Sequencing
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 CHIP Sequencing
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 De Novo Sequencing
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
6.7 Methyl Sequencing
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2019-2024)
- 6.7.3 Market Forecast (2025-2033)
6.8 Others
- 6.8.1 Historical and Current Market Trends (2019-2024)
- 6.8.2 Market Forecast (2025-2033)

7 Japan Next-Generation Sequencing Market - Breakup by Product Type

7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Reagents and Consumables
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Software and Services
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Next-Generation Sequencing Market - Breakup by Technology

8.1 Sequencing by Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Ion Semiconductor Sequencing
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Single-Molecule Real-Time Sequencing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Nanopore Sequencing
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Next-Generation Sequencing Market - Breakup by Application

9.1 Biomarker and Cancer
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Drug Discovery and Personalized Medicine
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Genetic Screening
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Diagnostics
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Agriculture and Animal Research
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
9.6 Others
- 9.6.1 Historical and Current Market Trends (2019-2024)
- 9.6.2 Market Forecast (2025-2033)

10 Japan Next-Generation Sequencing Market - Breakup by End User

10.1 Academic Institutes and Research Centers
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Hospitals and Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Pharmaceutical and Biotechnology Companies
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2019-2024)
- 10.4.2 Market Forecast (2025-2033)

11 Japan Next-Generation Sequencing Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Next-Generation Sequencing Market - Industry Analysis

13.1 Drivers, Restraints and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis